Financials in USD. Standardized financial statements.
A compact view of how IsoPlexis Corporation turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Revenue? | $16.76M | $17.26M | $10.39M | $7.50M |
| Revenue Growth? | -2.9% | +66.1% | +38.4% | 0.0% |
| Cost of Revenue? | $17.69M | $8.49M | $4.97M | $3.26M |
| Gross Profit? | -$925,000 | $8.77M | $5.41M | $4.25M |
| Gross Margin? | -5.5% | +50.8% | +52.1% | +56.6% |
| Operating Expenses? | $95.57M | $85.09M | $28.57M | $17.86M |
| Operating Income? | -$101.23M | -$76.32M | -$23.16M | -$13.62M |
| EBITDA? | -$91.54M | -$77.27M | -$22.28M | -$13.12M |
| Income Before Tax | -$106.00M | -$81.57M | -$23.26M | -$13.63M |
| Income Tax Expense | $9.51M | $1.99M | $21,000 | $1,000 |
| Net Income? | -$115.50M | -$83.56M | -$23.29M | -$13.63M |
| EPS? | $-2.94 | $-8.16 | $-0.60 | $-0.35 |
| Diluted EPS? | $-2.94 | $-8.16 | $-0.60 | $-0.35 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality